PURPOSETo investigate whether the addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to secondary cytoreductive surgery (SCS) without neoadjuvant chemotherapy has a benefit on progression-free survival (PFS), as opposed to SCS alone in patients …
PURPOSETo investigate whether intermittent treatment after an induction phase of first-line schedule of fluorouracil, leucovorin, and irinotecan (FOLFIRI) plus panitumumab (PAN) prevents or delays the…
Discover the latest advancements in pancreatic cancer vaccines and how they aim to prevent recurrent cancer by targeting specific mutations. Stay informed with current trials…
A new BLA for datopotamab deruxtecan aims for FDA accelerated approval to treat EGFR-mutated NSCLC based on data from multiple TROPION trials, following FDA feedback.
Aggressive features of hepatocellular carcinoma (HCC) are highly related to liver tumor-initiating cells (TICs), which are heterogeneous and plastic. In this issue of Cancer Cell,…
This report was compiled by NORC at the University of Chicago on behalf of the Consumer Representatives to the NAIC. The report examines the current…
Approximately one-third of patients with pancreatic cancer and anxiety had a palliative care consultation, data showed.
Catching cancer early can mean more treatment options and better outcomes. But when it comes to lung cancer, early detection can be a challenge. Symptoms…
Average risk women should begin annual screening at age 40
Characteristics of oncology patients most likely to have a potentially preventable emergency department visit were identified.
PHILADELPHIA (November 19, 2024) — A study led by a researcher at Fox Chase Cancer Center provides new insights into the cellular composition and microenvironment…
